Skip to content
Health · Russia

Bloomberg journalist Sam Fazeli provides the list of reasons to trust Russian vaccine Sputnik V. These reasons are: Russia with this vaccine is fifth on the list of vaccine makers with the most doses under contract through pre-purchase agreements; Sputnik V has been tested in a phase III trial; Efficacy at each interim analysis in the Sputnik V trial was consistently at 90% or above; Sputnik V was developed using the kind of advanced vaccine technology employed in shots made by the AstraZeneca-Oxford University. The journalist made evidence that the Sputnik V vaccine may well be as strong a candidate as the ones created in Western labs. He also stated that he would opt for a ride on Sputnik rather than a trip to CoronaVac’s golden stars.

Is it true?

Falseaccording to EUvsDisinfo

EUvsDisinfo checked this claim on 10 January 2021.

“disinformation”

  1. English

    Read the fact-check at EUvsDisinfo

Around this claim

First seen
10 January 2021, 1prime.ru, according to EUvsDisinfo (EEAS East StratCom Task Force) · and 6 more

Where it turned up

  • Seen at 1prime.ru, according to EUvsDisinfo (EEAS East StratCom Task Force), 10 January 2021
  • Seen at iz.ru, according to EUvsDisinfo (EEAS East StratCom Task Force), 10 January 2021
  • Seen at lenta.ru, according to EUvsDisinfo (EEAS East StratCom Task Force), 10 January 2021
  • Seen at lt.sputniknews.ru, according to EUvsDisinfo (EEAS East StratCom Task Force), 10 January 2021
  • Seen at regnum.ru, according to EUvsDisinfo (EEAS East StratCom Task Force), 10 January 2021
  • Seen at russian.rt.com, according to EUvsDisinfo (EEAS East StratCom Task Force), 10 January 2021
  • Seen at vz.ru, according to EUvsDisinfo (EEAS East StratCom Task Force), 10 January 2021

Related

NamesBloomberg L.P.AstraZenecaRussia

Something wrong here? Report it by emailinfo@factiz.org

The verdict belongs to the newsroom: report an error in it to them, through their article above. Report an error in what Factiz added, such as the translation, the theme or the names, to us.

Record from: EUvsDisinfo, European External Action Service. Licence: EEAS legal notice: reuse is authorised, provided the source is acknowledged; snapshot: Mendeley Data yhdtkszvgp v3, CC BY 4.0.

The sources are the verdict.